SCHEMBL370465

SCHEMBL370465

Cc1ccccc1C(CC(=NO)c1ccc(=O)n(C)c1)c1ccc(C2CCN(S(N)(=O)=O)CC2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPBAR1 Q8TDU6 6/20 0.46
USP5 P45974 4/20 0.36
CCR5 P51681 4/20 0.33
APAF1 O14727 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33
CA12 O43570 1/20 0.32
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
CA7 P43166 1/20 0.32
CA9 Q16790 1/20 0.32
CA14 Q9ULX7 1/20 0.32
MEN1 O00255 1/20 0.32
ALDH1A1 P00352 1/20 0.32
LMNA P02545 1/20 0.32
TSHR P16473 1/20 0.32
MAPK1 P28482 1/20 0.32
HTT P42858 1/20 0.32
KMT2A Q03164 1/20 0.32
MMP2 P08253 1/20 0.32
MMP13 P45452 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL370463 1.00 GPBAR1 (0.46) GPBAR1USP5CCR5APAF1HDAC6
SCHEMBL370466 1.00 GPBAR1 (0.46) GPBAR1USP5CCR5APAF1HDAC6
SCHEMBL370464 1.00 GPBAR1 (0.46) GPBAR1USP5CCR5APAF1HDAC6
SCHEMBL369926 0.93 GPBAR1 (0.46) GPBAR1USP5CCR5APAF1HDAC6
SCHEMBL369923 0.93 GPBAR1 (0.46) GPBAR1USP5CCR5APAF1HDAC6
SCHEMBL369924 0.93 GPBAR1 (0.46) GPBAR1USP5CCR5APAF1HDAC6
SCHEMBL369925 0.93 GPBAR1 (0.46) GPBAR1USP5CCR5APAF1HDAC6
SCHEMBL370024 0.89 GPBAR1 (0.40) GPBAR1USP5CCR5APAF1HDAC6
SCHEMBL370023 0.89 GPBAR1 (0.40) GPBAR1USP5CCR5APAF1HDAC6
SCHEMBL369364 0.88 GPBAR1 (0.46) GPBAR1APAF1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2593426-B1 1-HYDROXYIMINO-3-PHENYL-PROPANES HOFFMANN LA ROCHE (CH) 2014-08-20 EP claimed
EP-2593426-B1 1-HYDROXYIMINO-3-PHENYL-PROPANES HOFFMANN LA ROCHE (CH) 2014-08-20 EP disclosed
US-8765730-B2 1-hydroxyimino-3-phenyl-propanes Hoffmann-La Roche Inc (US) 2014-07-01 US disclosed
EP-2593426-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F.HOFFMANN-LA ROCHE AG (CH) 2013-05-22 EP disclosed
WO-2012007365-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-19 WO disclosed
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES GPBAR1, GPR119, ADRB1 GPBAR1 1/4885USP5 3695/4885CCR5 1943/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.